M*Modal Enhances its Artificial Intelligence Platform to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
300
M*Modal Enhances its Artificial Intelligence Platform to Support the Epic NoteReader CDI Workflow

FRANKLIN, TN--(Marketwired - June 14, 2017) - M*Modal, a leading provider of clinical documentation and Speech Understanding™ solutions, announced that its artificial intelligence (AI) powered portfolio of solutions is further enhanced to also support the Epic NoteReader CDI (Clinical Documentation Improvement) module. Along with the embedded M*Modal Computer-Assisted Physician Documentation (CAPD) technology, Epic NoteReader CDI also utilizes the M*Modal CAPD infrastructure and rigorous reporting capabilities to deliver automated physician feedback.

The M*Modal CAPD technology continuously analyzes the documentation and applies machine learning and clinical reasoning across the entire patient record to deliver high-value insights and suggest improvements in quality and compliance as the note is being created. Uniquely, M*Modal CAPD technology extends significantly beyond CDI feedback focused on better capturing Hierarchical Condition Categories (HCCs), Risk-Adjusted Quality Scores, etc.

This extends M*Modal's collaboration with Epic on the company's cloud-based speech recognition and natural language understanding technologies. Already utilized by several joint clients, these advanced workflows enable the M*Modal technology platform to analyze clinical notes and deliver real-time physician feedback on gaps and variance in problem, medication and allergy lists.

"Building on top of Epic's platform, M*Modal's innovative speech and AI tools give physicians great options for capturing narrative and structured data," said Carl Dvorak, President of Epic.

Leveraging Extensive Experience with CAPD

The work between the two companies to embed CAPD technology in the EHR benefits considerably from M*Modal's robust experience with CAPD, which is an integral functionality of its 2017 #1 Best in KLAS, Speech Recognition: Front-End EMR, M*Modal Fluency Direct®. First-to-market, M*Modal CAPD has been in production use since 2014 and is now broadly deployed across 200 healthcare facilities and is being used by over 10,000 physicians daily. This includes more than 65 healthcare facilities that are using M*Modal CAPD while documenting care in their Epic EHR every day.

"Our collaboration is focused on bringing smarter physician assistive technology to market and we are very pleased with the broad success of our joint clients and their continued willingness to innovate with us," said Michael Finke, President of M*Modal.

CAPD Best Practices for Optimal Outcomes

M*Modal leverages best practices learned from years of experience with CAPD:

  • Silent Mode Analytics: The ability to effectively target and customize CAPD messages is critical to physician engagement and success. M*Modal aligns CAPD messages with physicians who need them the most by first collecting data "silently" in the background, without ever presenting anything to the physician. This data-driven approach ensures maximum improvement in documentation quality with minimal disruption to the physician workflow, and avoids alert fatigue or mistrust in the system.
  • Truly Real-Time, In-Workflow Feedback: For optimal clinical effectiveness, M*Modal CAPD delivers actionable support to physicians as they dictate or type the clinical note -- either proactively before it is saved in the EHR using M*Modal Fluency Direct or after it is saved by using the Epic NoteReader CDI workflow. Requiring no additional steps or clicks from the physician, M*Modal CAPD helps resolve gaps in documentation and patient care, thereby helping free up more physician time for patient care.
  • Back-End Support: To maximize CAPD effectiveness on the front-end, it is important to have back-end support that provides insights into whether clinicians are acting on, ignoring or dismissing the CAPD feedback. M*Modal's single-platform, closed-loop approach provides back-end users visibility into physician behavior and lets back-end CDI correction workflows inform front-end physician documentation practices.

About M*Modal

M*Modal is a leading healthcare technology provider of advanced clinical documentation solutions, enabling hospitals and physicians to enrich the content of patient electronic health records (EHR) for improved healthcare and comprehensive billing integrity. As one of the largest clinical transcription service providers in the U.S., with a global network of medical editors, M*Modal also provides advanced cloud-based Speech Understanding™ technology and data analytics that enable physicians and clinicians to include the context of their patient narratives into electronic health records in a single step, further enhancing their productivity and the cost-saving efficiency and quality of patient care at the point of care. For more information, please visit https://mmodal.com, Twitter, Facebook and YouTube.

Media Contact:
Aparna Prabhakar
267-535-7680
aparna.prabhakar@mmodal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 18

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 30

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 26

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 29

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 17

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 28

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 25

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

MarketWise's Strategic Position: Navigating Challenges Ahead

Updated Category News Views 123

MarketWise, Inc. (NASDAQ:MKTW) faced a rocky road since its SPAC merger back in July 2021. After initial pandemic-fueled growth due to retail investors diving into the market, the winds changed. Now, MarketWise's struggling under a mix of management shakeups and an unforgiving economic environment. Understanding MarketWise's Value Proposition The company's core business...

Continue Reading
NTT Emphasizes AI Cloud Development at R&D Forum 2024

Updated Category News Views 219

NTT's Commitment to Industry-Specific AI Solutions NTT Corporation hosted a groundbreaking forum in Tokyo to highlight its commitment to innovative solutions. This year’s R&D Forum showcased NTT's dedication to creating a sustainable society through the effective use of AI technology. During the event, NTT President and CEO Akira Shimada discussed the Innovative Optical...

Continue Reading
Oculis Enhances Financial Flexibility with Expanded Loan Facility

Updated Category News Views 146

Oculis Enhances Financial Flexibility with Expanded Loan Facility Oculis Holding AG (Nasdaq: OCS; Iceland: OCS) has made a strategic move to bolster its financial resources. The biopharmaceutical company, dedicated to addressing critical unmet medical needs in ophthalmology and neuro-ophthalmology, revealed they have entered into an amended loan agreement with BlackRock....

Continue Reading
Abbott's New Glucose Monitor: A Game Changer for Consumers

Updated Category News Views 85

Abbott Launches Innovative Glucose Monitoring Solution Abbott has recently made a significant impact in the health technology field with the introduction of its eagerly awaited over-the-counter continuous glucose monitoring system called Lingo, now available in the United States. This state-of-the-art device is specifically designed for consumers aged 18 and older who do...

Continue Reading
Longshot Partners with Mettle Ops in SHIELD Contract Win

Updated Category News Views 154

Longshot and Mettle Ops Join Forces in a Major Contract Longshot, a prominent defense and space technology firm, has joined the Mettle Ops team to secure a position on the Missile Defense Agency's (MDA) prestigious Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) Indefinite Delivery/Indefinite Quantity (IDIQ) contract. This contract opens exciting...

Continue Reading